93 3145 93 3145
Pill imprint 93 3145 93 3145 has been identified as Cephalexin monohydrate 250 mg.
Cephalexin is used in the treatment of bacterial infection; bladder infection; upper respiratory tract infection; skin infection; kidney infections (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy.
Cephalexin 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Cephalexin monohydrate Images
- Imprint:
-
93 3145
93 3145 - Strength:
- 250 mg
- Color:
- Gray & Red
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
silicon dioxide
sodium starch glycolate type A potato
ferrosoferric oxide
D&C Yellow No. 10
aluminum oxide
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
carboxymethylcellulose sodium
sodium lauryl sulfate
titanium dioxide
propylene glycol
ferric oxide yellow
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-3145
Advertisement
More Cephalexin Monohydrate resources
- Cephalexin
- Cephalexin (Wolters Kluwer)
- Cephalexin Capsules (Wolters Kluwer)
- Cephalexin Suspension (Wolters Kluwer)
- cephalexin (Cerner Multum)
- Novo-Lexin (Micromedex) - Includes Dosage Information
- Panixine DisperDose (Micromedex) - Includes Dosage Information
- cephalexin (Micromedex) - Includes Dosage Information
- Cephalexin (AHFS DI)
- Cephalexin (FDA)
- Cephalexin Suspension (FDA)
- Cephalexin (Wolters Kluwer)
Search Again
